Skip to content

A Randomized Clinical Study Comparing Xenograft Against Demineralized Freeze-Dried Bone Allograft (DFDBA) in Ridge Preservation for Maxillary Anterior Sites, followed by Implant Placement.

Ridge Preservation in Maxillary Anterior Sites Comparing Xenograft Versus Indigenously Prepared Demineralized Freeze-Dried Bone Graft (DFDBA) With Subsequent Implant Placement: A Randomized Clinical Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067479
Enrollment
16
Registered
2024-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: K089- Disorder of teeth and supporting structures, unspecified Health Condition 3: K083- Retained dental root

Interventions

Intervention1: Demineralized Freeze Dried Bone Allograft.: Demineralized Freeze Dried Bone Allograft will be utilized in particle form within the extracted socket only once after the extraction of the

Sponsors

Jwngmashri Basumatary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of either sex between the age group of 18-16 years, who sign informed consent form for the study. 2. Subjects in whom extraction is indicated in at least one single rooted tooth in anterior maxilla. 3. Clinical root length should be equal to or greater than 8mm. 4. The presence of more than 50% of the buccal bone height. 5.Subjects who is compliant to maintain oral hygiene instructions 6. To select only sites where the tooth location and root angulation is consistent with the ideal implant orientation, where interocclusal distance is adequate for a dental implant placement. 7. Non-smokers.

Exclusion criteria

Exclusion criteria: 1. Teeth adjacent to the concerned tooth should not have any periapical or active periodontal disease. 2. Pregnant women or expected pregnancy during the study period. 3. Lactating women. 4. Subjects with bone disease (Paget disease, Rickets, Osteoporosis, Multiple Myeloma etc.) and Radiographic evidence of bone tumour (benign/malignant) or cyst. 5. Subjects under long-term bisphosphonate therapy. 6. Subjects with uncontrolled systemic diseases taking immunosuppressive/ anticoagulant medications. 7. Any medical condition that contraindicates surgery. 8. Any known history of allergy to medications and graft materials used in the study.

Design outcomes

Primary

MeasureTime frame
1. Changes in the bucco-palatal width of the alveolar ridge. 2. Changes in the vertical height of the alveolar ridge. 3. Changes in soft tissue (width and thickness of keratinised gingiva).Timepoint: 1. Baseline 2. 6months

Secondary

MeasureTime frame
1.To assess the clinical adverse effects of the grafts, if any. 2.Changes in clinical attachment level (CAL) at teeth adjacent to the extraction siteTimepoint: 1. Baseline 2. 6months

Countries

India

Contacts

Public ContactDr Jwngmashri Basumatary

Maulana Azad Institute of Dental Sciences

tandonshruti16@gmail.com9654700982

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026